Status:
TERMINATED
Age Versus Ovarian Reserve Markers Based Therapy in IVF (IVF)/Intracytoplasmic Sperm Injection (ICSI) Cycles
Lead Sponsor:
Andros Day Surgery Clinic
Conditions:
In Vitro Fertilization
Ovarian Stimulation
Eligibility:
FEMALE
18-40 years
Phase:
PHASE4
Brief Summary
This randomized controlled trial has been designed for carrying out a comparison of new AMH (Anti-Müllerian Hormone)-based individualized treatment (using a nomogram) with the wide accepted age-based ...
Detailed Description
Before clinicians can adopt any model into routine clinical practice, the accuracy of the model should be independently evaluated in a population different from the one on which the model was elaborat...
Eligibility Criteria
Inclusion
- first or second IVF/ICSI attempt (the second one after 6 months from the first one);regular menstrual cycles (25-33 days);female age ≤ 40; day 3 FSH ≤ 15IU/L;treatment with a long GnRH agonist protocol (buserelin)+rFSH;BMI: \>18 and ≤ 25 kg/m2;presence of both ovaries.
Exclusion
- irregular cycles, anovulatory infertility, endometriosis III-IV stage AFS, use of adjunctive therapies for stimulation, evidence of PCO status, previous ovarian surgery, presence of ovarian cysts, history of PID, use of hormonal contraception in the previous 3 months, any known metabolic or endocrinological disease, AMH levels \< 1 and \> 4.0 ng/ml
Key Trial Info
Start Date :
March 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2016
Estimated Enrollment :
194 Patients enrolled
Trial Details
Trial ID
NCT01816789
Start Date
March 1 2013
End Date
July 1 2016
Last Update
December 23 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ANDROS Day Surgery Clinic
Palermo, Sicily, Italy, 90144